688656.SH
浩欧博
SSE · Healthcare · Medical - Devices · CN
CNY 94.88
−6.78%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 399.7M | 398.4M | 402.3M | 394.4M | 320.4M |
| Cost of Revenue | 167.2M | 165.6M | 145.2M | 149.4M | 118.1M |
| Gross Profit | 232.5M | 232.8M | 257.2M | 245.0M | 202.3M |
| Operating Expenses | |||||
| R&D Expense | 47.2M | 47.8M | 46.3M | 47.0M | 38.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 63.2M | 62.7M | 65.6M | 45.3M | 39.5M |
| Selling & Marketing Expense | 97.3M | 96.6M | 94.3M | 94.1M | 78.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 217.6M | 216.9M | 215.6M | 192.4M | 161.6M |
| Cost and Expenses | 384.8M | 382.5M | 360.8M | 341.8M | 279.8M |
| Operating Income (EBIT) | 25.2M | 26.8M | 41.4M | 55.8M | 47.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 23.2M | 24.8M | 41.0M | 56.6M | 46.5M |
| Income Tax Expense | 1.5M | 1.6M | 4.2M | 9.3M | 4.8M |
| Bottom Line | |||||
| Net Income | 21.7M | 23.2M | 36.8M | 47.3M | 41.7M |
| Earnings from Cont. Ops | 21.7M | 23.2M | 36.8M | 47.3M | 41.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 21.7M | 23.2M | 36.8M | 47.3M | 41.7M |
| Per Share | |||||
| Basic EPS | CN¥0.34 | CN¥0.37 | CN¥0.59 | CN¥0.75 | CN¥0.66 |
| Diluted EPS | CN¥0.34 | CN¥0.37 | CN¥0.58 | CN¥0.74 | CN¥0.66 |
| Revenue Per Share | CN¥6.76 | CN¥6.35 | CN¥6.45 | CN¥6.25 | CN¥5.08 |
| Shares | |||||
| Basic Shares Outstanding | 59.1M | 62.7M | 62.4M | 63.1M | 63.1M |
| Diluted Shares Outstanding | 59.1M | 62.7M | 62.4M | 63.1M | 63.1M |
| Profitability Metrics | |||||
| EBITDA | — | 95.0M | 90.2M | 96.8M | 79.8M |
| D&A | — | 68.1M | 48.8M | 40.9M | 32.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026